1. 1) Freifeld A. G., Bow E. J., Sepkowitz K. A., Boeckh M. J., Ito J. I., Mullen C. A., Raad I. I., Rolston K. V., Young J. A., Wingard J. R., Clin. Infect. Dis., 52, 427-431 (2011).
2. 2) Committee for Guideline for treatment of Deep-seated Mycoses, “Guidelines for Management of Deep-seated Mycoses 2014,” ed. by Mycosis Forum, Kyowa Kikaku Ltd. Tokyo, 2014, pp. 127-129.
3. 3) Togano T., Shibuya K., Kume H., Med. Mycol. J., 53, 53-58 (2012).
4. 4) Japanese Society of Medical Oncology, “Practical Guideline of Febrile Neutropenia,” ed. by Japanese Society of Medical Oncology, Nankodo Co., Ltd., Tokyo, 2012, pp. 1-70.
5. 5) Schuler U., Bammer S., Aulitzky W. E., Binder C., Böhme A., Egerer G., Sandherr M., Schwerdtfeger R., Silling G., Wandt H., Glasmacher A., Ehninger G., Onkologie, 30, 185-191 (2007).